Lazard Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-484	Closed	-$696K	–	1055
2018 Q3	$696K	Buy	+484	New	+$696K	﹤0.01%	792
2018 Q2	–	Sell	-162	Closed	-$262K	–	1064
2018 Q1	$262K	Buy	+162	New	+$262K	﹤0.01%	816